BIIB
Biogen Inc
Price:  
221.02 
USD
Volume:  
1,070,694.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Biogen EV/EBITDA

59.1%
Upside

As of 2024-03-05, the EV/EBITDA ratio of Biogen Inc (BIIB) is 14.96. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Biogen's latest enterprise value is 38,015.77 mil USD. Biogen's TTM EBITDA according to its financial statements is 2,541.20 mil USD. Dividing these 2 quantities gives us the above Biogen EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 15.7x - 25.7x 20.4x
Forward P/E multiples 21.5x - 31.8x 26.0x
Fair Price 234.31 - 484.25 351.62
Upside 6.0% - 119.1% 59.1%
221.02 USD
Stock Price
351.62 USD
Fair Price

Biogen EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-03-04 14.96
2024-03-01 14.96
2024-02-29 14.73
2024-02-28 15.00
2024-02-27 15.13
2024-02-26 15.11
2024-02-23 15.09
2024-02-22 15.04
2024-02-21 14.96
2024-02-20 14.86
2024-02-16 14.85
2024-02-15 15.09
2024-02-14 14.94
2024-02-13 15.28
2024-02-12 16.32
2024-02-09 16.10
2024-02-08 16.06
2024-02-07 16.08
2024-02-06 16.36
2024-02-05 16.15
2024-02-02 16.26
2024-02-01 16.49
2024-01-31 16.43
2024-01-30 16.45
2024-01-29 16.48
2024-01-26 16.32
2024-01-25 16.40
2024-01-24 16.46
2024-01-23 16.71
2024-01-22 16.52
2024-01-19 16.62
2024-01-18 16.44
2024-01-17 16.35
2024-01-16 16.40
2024-01-12 16.51
2024-01-11 16.46
2024-01-10 16.86
2024-01-09 16.95
2024-01-08 17.07
2024-01-05 17.07
2024-01-04 17.21
2024-01-03 17.39
2024-01-02 17.63
2023-12-29 17.12
2023-12-28 17.22
2023-12-27 17.30
2023-12-26 17.23
2023-12-22 17.07
2023-12-21 16.84
2023-12-20 16.51